{"id":"2ab83a8dd33e","type":"article","url":"https://hartvaat.nl/2025/01/01/polygeen-risico-gestuurde-detectie-en-behandeling-van-subklinische-coronaire-ath/","title":"Polygeen risico-gestuurde detectie en behandeling van subklinische coronaire atherosclerose (PROACT)","title_en":"Polygenic Risk Based Detection and Treatment of Subclinical Coronary Atherosclerosis in the PROACT Clinical Trials","category":"algemeen","category_label":"Algemeen","professions":["cardioloog","huisarts"],"tags":["biomarkers-cardiovasculair"],"journal":"JACC","doi":"https://www.sciencedirect.com/science/article/pii/S0735109725105639?dgcid=rss_sd_all","source_url":"https://doi.org/https://www.sciencedirect.com/science/article/pii/S0735109725105639?dgcid=rss_sd_all","authors":["Roukoz Abou-Karam","Min Seo Kim","So Mi Jemma Cho","Fouad Bitar","Shoshana Gady","Fangzhou Cheng","Abigail Grace Thompson","Elizabeth W. Karlson","Pradeep Natarajan","Patrick T. Ellinor"],"significance":7,"published":"2026-03-01","source_date":"2025-01-01","image":"","kennis":["https://hartvaat.nl/kennis/cardiometabool/inflammatie-en-atherosclerose/","https://hartvaat.nl/kennis/coronairlijden/nitraten-bij-angina/"],"congress":"","summary_en":"The PROACT clinical trial results demonstrated the use of polygenic risk scores for detecting and treating subclinical coronary atherosclerosis, exploring genetics-guided prevention before clinical events occur.","created":"2026-07-03T10:25:46Z","updated":"2026-07-03T13:25:09Z","licence":"Citeer vrij, met bronvermelding en een link naar hartvaat.nl (de url van het record). Samenvattingen zijn redactioneel werk van HartVaat; de oorspronkelijke publicaties blijven van hun uitgevers (doi). Geen medisch advies.","body_markdown":"Resultaten van de PROACT-trials over het gebruik van polygene risicoscores voor detectie en behandeling van subklinische coronaire atherosclerose.","abstract_original":"Publication date: Available online 18 February 2026Source: JACC"}